The essential role of recombinant phage display antibody libraries
Drug Target Review
OCTOBER 3, 2024
This comprehensive toolbox of Type 1, Type 2, Type 3 and Type 4 anti-idiotypic antibodies provides PK and ADA assay developers with enhanced flexibility for a thorough analysis of antibody candidates. FDA no longer needs to require animal tests before human drug trials [Internet]. Adapted from Harth S et al. (8)
52 
Let's personalize your content